tiprankstipranks
Advertisement
Advertisement

ABBV Stock Latest News

AbbVie Targets Ovarian Cancer Biomarkers With New FRa Concordance Study
Company AnnouncementsAbbVie Targets Ovarian Cancer Biomarkers With New FRa Concordance Study
6h ago
ABBV
AbbVie’s New AML Combo Trial Aims to Boost Its Oncology Pipeline
PremiumCompany Announcements
AbbVie’s New AML Combo Trial Aims to Boost Its Oncology Pipeline
6h ago
ABBV
Midday Fly By: Apple sinks after guidance, Amazon’s AWS powers beat
PremiumThe Fly
Midday Fly By: Apple sinks after guidance, Amazon’s AWS powers beat
6h ago
CL
BSX
AbbVie says ‘quite pleased’ with Skyrizi momentum
PremiumThe Fly
AbbVie says ‘quite pleased’ with Skyrizi momentum
8h ago
ABBV
AbbVie raises FY26 revenue view to about $67.6B from about $67.3B
PremiumThe Fly
AbbVie raises FY26 revenue view to about $67.6B from about $67.3B
9h ago
ABBV
AbbVie sees Q3 adjusted EPS $3.84-$3.88, consensus $3.84
PremiumThe FlyAbbVie sees Q3 adjusted EPS $3.84-$3.88, consensus $3.84
9h ago
ABBV
AbbVie sees FY26 adjusted gross margin ‘above 84% of sales’
Premium
The Fly
AbbVie sees FY26 adjusted gross margin ‘above 84% of sales’
9h ago
ABBV
AbbVie says continues to make ‘excellent progress’ advancing pipeline
Premium
The Fly
AbbVie says continues to make ‘excellent progress’ advancing pipeline
9h ago
ABBV
AbbVie reports Q2 adjusted EPS $3.65, consensus $3.61
PremiumThe Fly
AbbVie reports Q2 adjusted EPS $3.65, consensus $3.61
10h ago
ABBV
AbbVie cuts FY26 adjusted EPS view to $13.87-$14.07 from $13.91-$14.11
PremiumThe Fly
AbbVie cuts FY26 adjusted EPS view to $13.87-$14.07 from $13.91-$14.11
10h ago
ABBV
Options Volatility and Implied Earnings Moves Today, July 31, 2026
PremiumMarket News
Options Volatility and Implied Earnings Moves Today, July 31, 2026
11h ago
D
CL
AbbVie’s New Phase 1 ABBV-859 Trial: Early Pipeline Signal for Long-Term Investors
PremiumCompany Announcements
AbbVie’s New Phase 1 ABBV-859 Trial: Early Pipeline Signal for Long-Term Investors
1d ago
ABBV
AbbVie’s ABBV-722 Clears Key Safety Hurdle in Contraceptive Interaction Study
PremiumCompany AnnouncementsAbbVie’s ABBV-722 Clears Key Safety Hurdle in Contraceptive Interaction Study
1d ago
ABBV
AbbVie announces Elahere availability in Singapore
Premium
The Fly
AbbVie announces Elahere availability in Singapore
3d ago
ABBV
AbbVie announces European Commission approval for Rinvoq
Premium
The Fly
AbbVie announces European Commission approval for Rinvoq
3d ago
ABBV
AbbVie price target raised to $300 from $275 at Barclays
PremiumThe Fly
AbbVie price target raised to $300 from $275 at Barclays
3d ago
ABBV
Abbvie (ABBV) Q2 Earnings Cheat Sheet
PremiumPre-Earnings
Abbvie (ABBV) Q2 Earnings Cheat Sheet
3d ago
ABBV
AbbVie’s ABBV-722 Phase 1 Milestone: What Early Safety Data Means for Investors
PremiumCompany Announcements
AbbVie’s ABBV-722 Phase 1 Milestone: What Early Safety Data Means for Investors
4d ago
ABBV
AbbVie Wraps Up Real-World RINVOQ Study in Psoriatic Arthritis: What Investors Should Watch
PremiumCompany Announcements
AbbVie Wraps Up Real-World RINVOQ Study in Psoriatic Arthritis: What Investors Should Watch
4d ago
ABBV
Options Volatility and Implied Earnings Moves This Week, July 27 – July 31, 2026
PremiumMarket NewsOptions Volatility and Implied Earnings Moves This Week, July 27 – July 31, 2026
4d ago
F
V
The Week That Was, The Week Ahead: Macro and Markets, July 26
Premium
Market News
The Week That Was, The Week Ahead: Macro and Markets, July 26
6d ago
F
O
AbbVie’s ABBV-313 Phase 1 Trial: What Early Safety Work Means for Investors
Premium
Company Announcements
AbbVie’s ABBV-313 Phase 1 Trial: What Early Safety Work Means for Investors
7d ago
ABBV

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >